期刊文献+

辣木籽提取物对缺血性脑卒中后轻度认知障碍的影响 被引量:1

The Effect of Moringa Oleifera Seed Extract on Mild Cognitive Impairment after Ischemic Stroke
下载PDF
导出
摘要 目的探讨辣木籽醇提物对缺血性脑卒中后轻度认知障碍的临床疗效。方法将患者随机分成2组,治疗组和对照组,治疗组给予辣木籽醇提取物胶囊2粒,每日2次,3个月,对照组给予尼莫地平片20 mg,每日2次,3个月,治疗前和治疗后分别评估MMSE和Co MA评分,检测患者血清中SOD、MDA、Ach E和p-Tau。结果相对于治疗前,治疗后患者MMSE和Co MA评分增加,P <0.05,血清中SOD升高,MDA降低,Ach E和p-Tau下降显著,P <0.05。结论辣木籽醇提物能够提高缺血性脑卒中后轻度认知障碍患者的MMSE和Co MA评分,改善患者的氧化应激反应,促进神经功能的恢复,改善认知能力,值得临床推广。 Objective To investigate the clinical effect of Moringa oleifera seed extract on mild cognitive impairment after ischemic stroke.Methods The patients were randomly divided into treatment group and control group.The treatment group was given 2 capsules of Moringa oleifera alcohol extract capsules twice a day for 3 months.The control group was given 20 mg of nimodipine tablets twice a day for 3 months.The scores of MMSE and CoMA were evaluated before and after treatment,and the serum SOD,MDA,AchE and p-Tau were detected.Results Compared with before treatment,the scores of MMSE and CoMA increased after treatment(P<0.05),SOD increased,MDA decreased,AchE and p-Tau decreased significantly(P<0.05).Conclusion The ethanol extract of Moringa oleifera seeds can improve the MMSE and CoMA scores of patients with mild cognitive impairment after ischemic stroke,improve the oxidative stress response of patients,promote the recovery of nerve function and improve cognitive ability,which is worthy of clinical promotion.
作者 杨武双 王幼娟 许东伟 刘金凤 YANGWushuang;WANG Youjuan;XU Dongwei;LIU Jinfeng(Neurosurgery Department,Xiamen Hospital of Traditional Chinese Medicine,Fujian Province,Xiamen 361009,China;Pharmacy Department,Xiamen Hospital of Traditional Chinese Medicine,Fujian Province,Xiamen 361009,China)
出处 《中国中医药现代远程教育》 2020年第7期102-104,共3页 Chinese Medicine Modern Distance Education of China
基金 厦门市卫生健康委员会项目【No.3502Z20159018】。
关键词 辣木籽 认知障碍 脑卒中 中风 Moringa oleifera seeds mild cognitive impairment cerebral apoplexy stroke
  • 相关文献

参考文献2

二级参考文献23

  • 1Petersen R C,Smith G E,Waring S C,et al.Mild cognitive:clinical characterization and outcome[J].Arch Neurol,1999,56(3):303-308.
  • 2Andreasen N,Blennow K.CSF biomarkers for mild cognitive impairment and early Alzheimer's disease[J].Clin Neurol Neurosurg,2005,107(3):165-173.
  • 3Fagn A M,Roe C M,Xiong C,et al.Cerebrospinal fluid tau/beta-amy-Loid42 ratio as prediction of cognitive decline in nondemented older a-dults[J].Arch Neurol,2007,64(3):343-349.
  • 4Li G,Sokal I,Quinn J F,et al.CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment:a follow-upstudy[J].Neurology,2007,7(69):631-639.
  • 5Zlokovic B V.Clearing amyloid through the blood-brain barrier.[J].Neuroehem,2004,89(4):807-811.
  • 6Hansson O,Zetterberg H,Vanmechelen E,et al.Evalufion of plasmaAβ40andAβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment[J].Neurobiology Aging,2010,31(3):539-540.
  • 7Lopez O L,KuUer L H,Mehta P D,et al.Plasma amyloid levels and the Risk of AD in normal subjects in the Gardiovascular Healthy Study[J].NeuroLogy,2008,70(19):1664-1671.
  • 8Fukumoto H,Tennis M,Loeaseio J J,et al.Age but not diagnosis is the main predictor of plasma amyloid-protein levels[J].Arch Neuro,2003,60(7):958-964.
  • 9Graff-Radford N R,Crook J E,Lucas J,et al.Association of low plasma Abeta42/Abeta40 ratioswith increased imminent risk formild cognitive impairment and Alsheimer disease[J].Arch Neurol,2007,64(3):354-362.
  • 10Ewers M,Buerger K,Teipal S J,et al.Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI[J].Neurology,2007,69(24):2205-2212.

共引文献130

同被引文献9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部